Elanco Galliprant

true {{custommediabasic::headline_all_caps}} {{custommediabasic::headline_less_padding_bottom}} #CF1A45 #CF1A45 {{custommediabasic::custom_background}} 30px 0 30px 0 https://www.galliprantvet.com/us/en /uploads/elanco_galliprant-b45b9f109423bebfe7f10c470610f1eb.png {{custommediabasic::logo_alt_text}} 270 {{custommediabasic::logo_at_bottom}} {{custommediabasic::header_image_url}} /uploads/elanco_e_blast_header_image_v_1_600_x_200_final-dadcf20aa52a4fd61d2558b3473f5d0a.jpg {{custommediabasic::header_image_alt_text}} GET DOGS BACK TO DOING WHAT THEY LOVE {{custommediabasic::headline_smaller}} And love the expressions they make when they’re doing it. {{custommediabasic::subhead_url}} true {{custommediabasic::headline_subhead_below_header_image}}

Join us in congratulating Elizabeth Thompson of the Humane Society of Missouri. She’s the winner of a customized Dubby Ludcke pet portrait. Thanks to everyone who entered to win by watching a video of inspiring stories about treating canine osteoarthritis (OA) pain.

{strong}EFFECTIVE CANINE OA PAIN RELIEF{/strong}

One key to your canine patients’ health is helping them stay active. Galliprant® (grapiprant tablets) delivers targeted, effective pain relief from the earliest diagnosed stages of canine OA. 

Galliprant can help you target canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis. {sup}1,2{/sup}

{strong}SELECT IMPORTANT SAFETY INFORMATION{/strong}

The safe use has not been evaluated in dogs less than 9 months of age and less than 8 lbs. If Galliprant is used long term, appropriate monitoring is recommended.

#202020 true true {{custommediabasic::cta_callout}} {{custommediabasic::cta_callout_secondary}} https://www.galliprantvet.com/us/en Learn more about Galliprant and get inspired. {{custommediabasic::button_text}} {{custommediabasic::footnote_center}} {{custommediabasic::footnote}} true {{custommediabasic::pre_footer_center}} {{custommediabasic::pre_footer_larger}}

{strong}INDICATION{/strong} Galliprant is an NSAID indicated for the control of pain and inflammation associated with osteoarthritis in dogs. 

{strong}IMPORTANT SAFETY INFORMATION{/strong} Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.

1. Kirkby Shaw K, Rausch-Derra LC, Rhodes, L. Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation. Vet Med Sci. 2016;2:3-9.

2. Rausch-Derra LC, Huebner M, Rhodes, L. Evaluation of the safety of long-term, daily oral administration of grapiprant, a novel drug for treatment of osteoarthritis pain and inflammation, in healthy dogs. Am J Vet Res. 2015;76:853-9.

© 2020 Elanco. Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-20-0759

{{custommediabasic::preview_text}}

{{custommediabasic::preview_text}}